Zhao S, Su W, Deng L, et al. - This study was undertaken to evaluate CT, magnetic resonance imaging (MRI), and combined 2-[¹⁸]-fluoro-2-deoxy-d-glucose (¹⁸F-FDG) positron-emission tomography (PET)/CT features of pancreatic sarcomatoid carcinoma (PSC). Researchers retrospectively searched the hospital database for the patients with PSC confirmed at histopathology after surgery. This study recruited ten individuals who underwent unenhanced and enhanced CT (n = 4), unenhanced and enhanced MRI (n = 2), ¹⁸F-FDG PET/CT (n = 2), and both enhanced CT and ¹⁸F-FDG PET/CT (n = 2). The maximum standardized uptake value (SUVmax) was estimated on PET/CT images. The pancreatic duct obstruction/compression without pancreatic parenchymal atrophy was produced by PSCs which are more commonly ill-defined solid cystic masses, and these masses on PET/CT confirmed high FDG uptake on both initial and delayed PET/CT.